HPV16 genetic variation provides evidence of positive natural selection driven by HLA class I.

Saved in:
Bibliographic Details
Title: HPV16 genetic variation provides evidence of positive natural selection driven by HLA class I.
Authors: Nelson CW; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. chase.nelson@nih.gov., Mishra SK; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Rockville, MD, USA., Dean M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA., Ohuigin C; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA.; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute Bethesda, Bethesda, MD, USA., Burk RD; Departments of Pediatrics, Epidemiology and Population Health, Microbiology and Immunology, and Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine, New York, NY, USA., Zhu B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA., Wang D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Rockville, MD, USA., Burdett L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Rockville, MD, USA., Viard M; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA.; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute Bethesda, Bethesda, MD, USA., Lee HJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Rockville, MD, USA., Koestler AJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA., Narechania A; Institute for Comparative Genomics, American Museum of Natural History, New York, NY, USA., Chen Z; Department of Microbiology, The Chinese University of Hong Kong, Hong Kong SAR, China., Wentzensen N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA., Schiffman M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA., Clifford GM; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer, Lyon, France., Suh-Burgmann E; Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA., Lorey T; Regional Laboratory and Women's Health Research Institute, Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA., Carrington M; Basic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, USA.; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute Bethesda, Bethesda, MD, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Yeager M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Rockville, MD, USA.; Department of Biology, Hood College, Frederick, MD, USA., Mirabello L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA. mirabellol@mail.nih.gov.
Source: Nature communications [Nat Commun] 2026 Jun 02; Vol. 17 (1). Date of Electronic Publication: 2026 Jun 02.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-026-73531-0